These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
320 related items for PubMed ID: 9267449
21. Influenza virus neuraminidase contributes to the dextran sulfate-dependent suppressive replication of some influenza A virus strains. Yamada H, Moriishi E, Haredy AM, Takenaka N, Mori Y, Yamanishi K, Okamoto S. Antiviral Res; 2012 Dec; 96(3):344-52. PubMed ID: 23022352 [Abstract] [Full Text] [Related]
22. Mechanism of the antiviral effect of hydroxytyrosol on influenza virus appears to involve morphological change of the virus. Yamada K, Ogawa H, Hara A, Yoshida Y, Yonezawa Y, Karibe K, Nghia VB, Yoshimura H, Yamamoto Y, Yamada M, Nakamura K, Imai K. Antiviral Res; 2009 Jul; 83(1):35-44. PubMed ID: 19501255 [Abstract] [Full Text] [Related]
23. 4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro. Woods JM, Bethell RC, Coates JA, Healy N, Hiscox SA, Pearson BA, Ryan DM, Ticehurst J, Tilling J, Walcott SM. Antimicrob Agents Chemother; 1993 Jul; 37(7):1473-9. PubMed ID: 8363379 [Abstract] [Full Text] [Related]
24. Characterization of 2 influenza A(H3N2) clinical isolates with reduced susceptibility to neuraminidase inhibitors due to mutations in the hemagglutinin gene. Abed Y, Bourgault AM, Fenton RJ, Morley PJ, Gower D, Owens IJ, Tisdale M, Boivin G. J Infect Dis; 2002 Oct 15; 186(8):1074-80. PubMed ID: 12355356 [Abstract] [Full Text] [Related]
25. Abortive replication of influenza virus A/WSN/33 in HeLa229 cells: defective viral entry and budding processes. Gujuluva CN, Kundu A, Murti KG, Nayak DP. Virology; 1994 Nov 01; 204(2):491-505. PubMed ID: 7941316 [Abstract] [Full Text] [Related]
26. Inhibition of influenza virus hemagglutinin-mediated membrane fusion by a compound related to podocarpic acid. Staschke KA, Hatch SD, Tang JC, Hornback WJ, Munroe JE, Colacino JM, Muesing MA. Virology; 1998 Sep 01; 248(2):264-74. PubMed ID: 9721235 [Abstract] [Full Text] [Related]
27. Highly potent and long-acting trimeric and tetrameric inhibitors of influenza virus neuraminidase. Watson KG, Cameron R, Fenton RJ, Gower D, Hamilton S, Jin B, Krippner GY, Luttick A, McConnell D, MacDonald SJ, Mason AM, Nguyen V, Tucker SP, Wu WY. Bioorg Med Chem Lett; 2004 Mar 22; 14(6):1589-92. PubMed ID: 15006410 [Abstract] [Full Text] [Related]
28. Glucosyl hesperidin prevents influenza a virus replication in vitro by inhibition of viral sialidase. Saha RK, Takahashi T, Suzuki T. Biol Pharm Bull; 2009 Jul 22; 32(7):1188-92. PubMed ID: 19571383 [Abstract] [Full Text] [Related]
29. Neuraminidase inhibitory activities of flavonols isolated from Rhodiola rosea roots and their in vitro anti-influenza viral activities. Jeong HJ, Ryu YB, Park SJ, Kim JH, Kwon HJ, Kim JH, Park KH, Rho MC, Lee WS. Bioorg Med Chem; 2009 Oct 01; 17(19):6816-23. PubMed ID: 19729316 [Abstract] [Full Text] [Related]
30. Antiviral effect of Sanicula europaea L. leaves extract on influenza virus-infected cells. Turan K, Nagata K, Kuru A. Biochem Biophys Res Commun; 1996 Aug 05; 225(1):22-6. PubMed ID: 8769089 [Abstract] [Full Text] [Related]
31. Zanamivir. A potent and selective inhibitor of influenza A and B viruses. Aoki FY, Hayden FG. Clin Pharmacokinet; 1999 Aug 05; 36 Suppl 1():v-ix. PubMed ID: 10429834 [No Abstract] [Full Text] [Related]
32. Potent inhibition of influenza sialidase by a benzoic acid containing a 2-pyrrolidinone substituent. Atigadda VR, Brouillette WJ, Duarte F, Ali SM, Babu YS, Bantia S, Chand P, Chu N, Montgomery JA, Walsh DA, Sudbeck EA, Finley J, Luo M, Air GM, Laver GW. J Med Chem; 1999 Jul 01; 42(13):2332-43. PubMed ID: 10395473 [Abstract] [Full Text] [Related]
33. Anti-influenza drug discovery: structure-activity relationship and mechanistic insight into novel angelicin derivatives. Yeh JY, Coumar MS, Horng JT, Shiao HY, Kuo FM, Lee HL, Chen IC, Chang CW, Tang WF, Tseng SN, Chen CJ, Shih SR, Hsu JT, Liao CC, Chao YS, Hsieh HP. J Med Chem; 2010 Feb 25; 53(4):1519-33. PubMed ID: 20092255 [Abstract] [Full Text] [Related]
34. Characterization of mutants of influenza A virus selected with the neuraminidase inhibitor 4-guanidino-Neu5Ac2en. Gubareva LV, Bethell R, Hart GJ, Murti KG, Penn CR, Webster RG. J Virol; 1996 Mar 25; 70(3):1818-27. PubMed ID: 8627706 [Abstract] [Full Text] [Related]
35. Suppression of influenza virus infection by an N-thioacetylneuraminic acid acrylamide copolymer resistant to neuraminidase. Itoh M, Hetterich P, Isecke R, Brossmer R, Klenk HD. Virology; 1995 Oct 01; 212(2):340-7. PubMed ID: 7571403 [Abstract] [Full Text] [Related]
36. A sialic acid-derived phosphonate analog inhibits different strains of influenza virus neuraminidase with different efficiencies. White CL, Janakiraman MN, Laver WG, Philippon C, Vasella A, Air GM, Luo M. J Mol Biol; 1995 Feb 03; 245(5):623-34. PubMed ID: 7844831 [Abstract] [Full Text] [Related]
37. Effect of coumermycin on influenza A virus replicative cycle. Portincasa P, Palu' G, Conti G, Pesce A, Chezzi C. Microbiologica; 1984 Apr 03; 7(2):121-32. PubMed ID: 6547762 [Abstract] [Full Text] [Related]
38. Anti-influenza virus activity of the neuraminidase inhibitor 4-guanidino-Neu5Ac2en in cell culture and in human respiratory epithelium. Hayden FG, Rollins BS, Madren LK. Antiviral Res; 1994 Oct 03; 25(2):123-31. PubMed ID: 7847874 [Abstract] [Full Text] [Related]
39. Anti-influenza drugs: the development of sialidase inhibitors. von Itzstein M, Thomson R. Handb Exp Pharmacol; 2009 Oct 03; (189):111-54. PubMed ID: 19048199 [Abstract] [Full Text] [Related]